Teva Pharmaceuticals will pay up to $523 million to New York to settle claims stemming from the company’s role in the opioid crisis.
Looking For Market Distribution? Download the Media Kit
Teva Pharmaceuticals will pay up to $523 million to New York to settle claims stemming from the company’s role in the opioid crisis.